Sun Xiao-le, Yang Zi, Wang Wei, Wang Xiao-ye, Wang Jia-lue, Wu Shu-ying
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. Email:
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):853-7.
To investigate the effects of expression of mitochondria long-chain fatty acid oxidative enzyme (long-chain 3 hyroxyacyl CoA dehydrogenase, LCHAD) and p38 mitogen activated protein kinase (p38MAPK) signal transduction pathway in severe preeclampsia.
Serum-free trophoblast cells cultured in vitro were stimulated by early onset severe preeclampsia serum (E-PE group), late onset severe preeclampsia serum (L-PE group), HELLP syndrome serum (HELLP group), and normal pregnancy serum (NP group) respectively; each group was added DMEM/F12 medium, reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor (NADPH-I) and p38MAPK inhibitor (p38-I) to stimulate cells. Expression of mRNA and protein of LCHAD in trophoblast cells were detected by real-time PCR and western blot.
(1)The expression of mRNA of LCHAD: the level of mRNA of LCHAD in NP+DMEM, E-PE+DMEM, E-PE+NADPH-I, E-PE+p38-I, L-PE+DMEM, L-PE+NADPH-I, L-PE+p38-I and HELLP+DMEM, HELLP+NADPH-I, HELLP+p38-I groups were 1.00 ± 0.03, 0.14 ± 0.08, 0.95 ± 0.20, 1.43 ± 1.02, 0.37 ± 0.18, 1.51 ± 0.36, 1.60 ± 0.31, 0.10 ± 0.04, 0.49 ± 0.10, 0.44 ± 0.21, respectively. The relative expressions of mRNA of LCHAD were significantly reduced in E-PE+DMEM, L-PE+DMEM and HELLP+DMEM groups compared with the NP+DMEM group (P < 0.05). Compared with the NP groups, the relative expressions of mRNA of LCHAD were significantly increased in L-PE+NADPH-I and L-PE+p38-I group (P < 0.05), while reduced in HELLP groups(P < 0.05). (2) The expression of protein of LCHAD: the relative expressions of protein of LCHAD in NP+DMEM, E-PE+DMEM, E-PE+NADPH-I, E-PE+p38-I, L-PE+DMEM, L-PE+NADPH-I, L-PE+p38-I and HELLP+ DMEM, HELLP+NADPH-I, HELLP+p38-I groups were 19.4 ± 2.2, 10.7 ± 1.1, 17.9 ± 3.3, 19.1 ± 2.9, 16.4 ± 2.3, 20.3 ± 2.3, 20.9 ± 4.3, 12.4 ± 2.3, 17.6 ± 2.6, 17.7 ± 2.0 respectively. Compared with the NP groups, the protein expressions of LCHAD were significantly remarkably reduced in E-PE+DMEM, L-PE+DMEM and HELLP groups (P < 0.05). Compared with the DMEM groups, the protein expressions of LCHAD were significantly increased in NADPH-I and p38-I groups of E-PE, L-PE and HELLP groups (P < 0.05).
These studies demonstrate that long chain fatty acid oxidation was involved in the pathogenesis and development of preeclampsia. The expressions of gene and protein of LCHAD were remarkably affected by early onset severe preeclampsia and HELLP syndrome. NADPH-I and p38-I may allay the disorder of fatty acid oxidation. p38MAPK signal transduction pathway may contributed in this process.
探讨线粒体长链脂肪酸氧化酶(长链3-羟酰基辅酶A脱氢酶,LCHAD)表达及p38丝裂原活化蛋白激酶(p38MAPK)信号转导通路在重度子痫前期中的作用。
体外培养的无血清滋养层细胞分别用早发型重度子痫前期血清(E-PE组)、晚发型重度子痫前期血清(L-PE组)、HELLP综合征血清(HELLP组)和正常妊娠血清(NP组)刺激;每组加入DMEM/F12培养基、还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶抑制剂(NADPH-I)和p38MAPK抑制剂(p38-I)刺激细胞。采用实时荧光定量PCR和蛋白质印迹法检测滋养层细胞中LCHAD的mRNA和蛋白表达。
(1)LCHAD的mRNA表达:NP+DMEM、E-PE+DMEM、E-PE+NADPH-I、E-PE+p38-I、L-PE+DMEM、L-PE+NADPH-I、L-PE+p38-I和HELLP+DMEM、HELLP+NADPH-I、HELLP+p38-I组LCHAD的mRNA水平分别为1.00±0.03、0.14±0.08、0.95±0.20、1.43±1.02、0.37±0.18、1.51±0.36、1.60±0.31、0.10±0.04、0.49±0.10、0.44±0.21。与NP+DMEM组比较,E-PE+DMEM、L-PE+DMEM和HELLP+DMEM组LCHAD的mRNA相对表达量显著降低(P<0.05)。与NP组比较,L-PE+NADPH-I和L-PE+p38-I组LCHAD的mRNA相对表达量显著升高(P<0.05),而HELLP组降低(P<0.05)。(2)LCHAD的蛋白表达:NP+DMEM、E-PE+DMEM、E-PE+NADPH-I、E-PE+p38-I、L-PE+DMEM、L-PE+NADPH-I、L-PE+p38-I和HELLP+DMEM、HELLP+NADPH-I、HELLP+p38-I组LCHAD的蛋白相对表达量分别为19.4±2.2、10.7±1.1、17.9±3.3、19.1±2.9、16.4±2.3、20.3±2.3、20.9±4.3、12.4±2.3、17.6±2.6、17.7±2.0。与NP组比较,E-PE+DMEM、L-PE+DMEM和HELLP组LCHAD的蛋白表达显著降低(P<0.05)。与DMEM组比较,E-PE、L-PE和HELLP组的NADPH-I和p38-I组LCHAD的蛋白表达显著升高(P<0.05)。
这些研究表明长链脂肪酸氧化参与子痫前期的发病机制和发展过程。早发型重度子痫前期和HELLP综合征显著影响LCHAD的基因和蛋白表达。NADPH-I和p38-I可能减轻脂肪酸氧化紊乱。p38MAPK信号转导通路可能在此过程中起作用。